Portal Biotechnologies
Next Gen Cell Engineering & Drug Discovery
United States · $12.0M raised
- Employees
- 11–50
- Business Model
- B2B
- Website
- portal.bio
- Total Funding
- $12.0M
- Last Round
- $7.0M SeedDec 2024
- Rounds
- 2
About
Next-generation cell engineering and drug discovery platform with over 50 biopharma and academic partners.
Summary
Portal Biotechnologies is a Biotech company based in United States. It has raised $12.0M in total across 2 rounds, most recently a $7.0M Seed round in Dec 2024. Investors include IA Ventures, Pear VC and IKJ Capital.
Tech & App Stack
6 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Dec 2024
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...